Get Ready for Hep C Meds Mavyret and Vosevi
You'll see big changes in treating hepatitis C due to the new oral antivirals, Mavyret and Vosevi.
Expect to get more involved in managing hep C...just like you're managing heart disease, diabetes, etc. The newer hep C meds are easier to initiate, require less monitoring, and are better tolerated.
Mavyret (MAV-ih-reht, glecaprevir/pibrentasvir) will be another game changer. It's the first hep C med approved for just 8 weeks for initial therapy of all genotypes for most patients without cirrhosis.